Y Combinator is pulling the curtains off of a new experiment, YC Bio. The idea is to fund early-stage life-sciences companies that are still in the lab phase, YC President Sam Altman wrote on the YC blog today. YC Bio’s first area of focus will be on healthspan and age-related disease. Read More
from TechCrunch http://ift.tt/2mtKYEL
from TechCrunch http://ift.tt/2mtKYEL
No comments:
Post a Comment